DK2254573T3 - Sammensætninger omfattende phytoøstrogener selektive for østrogenbetareceptor- og diætfibre - Google Patents

Sammensætninger omfattende phytoøstrogener selektive for østrogenbetareceptor- og diætfibre

Info

Publication number
DK2254573T3
DK2254573T3 DK09712828.4T DK09712828T DK2254573T3 DK 2254573 T3 DK2254573 T3 DK 2254573T3 DK 09712828 T DK09712828 T DK 09712828T DK 2254573 T3 DK2254573 T3 DK 2254573T3
Authority
DK
Denmark
Prior art keywords
bettery
phyto
estrogens
estrogen
receptor
Prior art date
Application number
DK09712828.4T
Other languages
English (en)
Other versions
DK2254573T5 (da
Inventor
Leo Alfredo Di
Michele Barone
Original Assignee
Cm & D Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm & D Pharma Ltd filed Critical Cm & D Pharma Ltd
Publication of DK2254573T3 publication Critical patent/DK2254573T3/da
Application granted granted Critical
Publication of DK2254573T5 publication Critical patent/DK2254573T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
DK09712828.4T 2008-02-22 2009-02-20 Sammensætninger omfattende phytoøstrogener selektive for østrogenbetareceptor- og diætfibre DK2254573T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000008A ITBA20080008A1 (it) 2008-02-22 2008-02-22 Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
PCT/EP2009/052038 WO2009103788A1 (en) 2008-02-22 2009-02-20 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres

Publications (2)

Publication Number Publication Date
DK2254573T3 true DK2254573T3 (da) 2012-08-20
DK2254573T5 DK2254573T5 (da) 2012-09-17

Family

ID=40291378

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09712828.4T DK2254573T5 (da) 2008-02-22 2009-02-20 Sammensætninger omfattende phytoøstrogener selektive for østrogenbetareceptor- og diætfibre

Country Status (20)

Country Link
US (2) US20110027230A1 (da)
EP (1) EP2254573B9 (da)
JP (1) JP2011512386A (da)
KR (1) KR20100131985A (da)
CN (1) CN101951900A (da)
BR (1) BRPI0908493A2 (da)
CA (1) CA2714668C (da)
CO (1) CO6361919A2 (da)
DK (1) DK2254573T5 (da)
EA (1) EA020095B1 (da)
ES (1) ES2387530T3 (da)
IL (1) IL207670A (da)
IT (1) ITBA20080008A1 (da)
MX (1) MX2010009021A (da)
MY (1) MY150407A (da)
NZ (1) NZ587116A (da)
PT (1) PT2254573E (da)
UA (1) UA101178C2 (da)
WO (1) WO2009103788A1 (da)
ZA (1) ZA201006767B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013045068A1 (en) 2011-09-30 2013-04-04 Cm&D Pharma Limited Compositions comprising phytoestrogens receptor beta agonists and dietary fibres for chemopreventive treatment of sporadic adenomatous polyposis
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
US20150098978A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tablet
CA3228982A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
EP3636077B1 (en) 2015-01-26 2022-11-16 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
CN107771083A (zh) 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
US10869495B2 (en) * 2015-10-19 2020-12-22 Famenity Co., Ltd. Functional composition for improvement and prevention of estrogen deficiency in menopausal women
CN106822217B (zh) * 2017-02-20 2020-05-05 天津医科大学总医院 蔓越莓冻干粉在制备防治家族性腺瘤性息肉病药物中的应用
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
WO2020161522A1 (en) 2019-02-06 2020-08-13 Thd S.P.A. Fiber-based composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625129D0 (en) 1996-12-03 1997-01-22 Cerestar Holding Bv Highly fermentable resistant starch
JP3497362B2 (ja) * 1997-11-12 2004-02-16 株式会社朝日商事 発癌抑制薬
ES2384452T3 (es) * 1999-02-24 2012-07-05 The Iams Company Composición alimentaria y métodos
WO2001021165A1 (en) * 1999-09-21 2001-03-29 Rutgers, The State University Resveratrol analogs for prevention of disease
WO2003049689A2 (en) * 2001-12-06 2003-06-19 Nutraceutix, Inc. Isoflavone composition for oral delivery
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
CZ20033042A3 (cs) * 2003-11-10 2005-06-15 Naturprodukt Cz Spol. S R. O. Potravinový doplněk na bázi silymarinu
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
EP2046352A4 (en) * 2006-06-06 2012-03-21 Univ Mcgill FERMENTED MILK PRODUCT AND ITS USE

Also Published As

Publication number Publication date
CO6361919A2 (es) 2012-01-20
ITBA20080008A1 (it) 2009-08-23
ES2387530T3 (es) 2012-09-25
WO2009103788A1 (en) 2009-08-27
BRPI0908493A2 (pt) 2019-09-24
MY150407A (en) 2014-01-15
US20140105864A1 (en) 2014-04-17
CA2714668C (en) 2017-01-10
EA020095B1 (ru) 2014-08-29
ES2387530T9 (es) 2013-01-15
EA201001343A1 (ru) 2011-02-28
ZA201006767B (en) 2011-06-29
UA101178C2 (ru) 2013-03-11
MX2010009021A (es) 2010-11-12
US20110027230A1 (en) 2011-02-03
EP2254573A1 (en) 2010-12-01
EP2254573B1 (en) 2012-05-16
NZ587116A (en) 2012-02-24
IL207670A0 (en) 2010-12-30
EP2254573B9 (en) 2012-09-26
KR20100131985A (ko) 2010-12-16
IL207670A (en) 2013-12-31
DK2254573T5 (da) 2012-09-17
PT2254573E (pt) 2012-08-08
JP2011512386A (ja) 2011-04-21
WO2009103788A9 (en) 2010-02-04
CN101951900A (zh) 2011-01-19
AU2009216653A1 (en) 2009-08-27
CA2714668A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
DK2254573T5 (da) Sammensætninger omfattende phytoøstrogener selektive for østrogenbetareceptor- og diætfibre
EP2170067A4 (en) LIQUIRITIGENIN AND ITS DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS
HK1144821A1 (en) Glucocorticoid receptor agonists
IL248245A0 (en) Preparations containing a sex steroid precursor with a selective estrogen receptor variety and uses thereof
EP2173174A4 (en) FARNESOID X RECEPTOR AGONISTS
EP2170072A4 (en) Farnesoid X RECEPTOR AGONISTS
EP2079307A4 (en) FARNESOID RECEPTOR AGONISTS X
ATE465169T1 (de) Hemmstoffe des progesteron-rezeptors
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
GB2445036B (en) Device for reducing fibrous products
HK1131396A1 (en) 11-phosphorous steroid derivatives useful as progesterone receptor modulators
GB2445230B (en) Dilution device
ATE478078T1 (de) Pyridooxazepin-progesteronrezeptor-modulatoren
DK2176282T3 (da) 8-beta-substituted estratrienes as selectively active estrogens
GB0705829D0 (en) Waste receptor
BRPI0920825A2 (pt) modulador seletivo do receptor de estrogênio
HK1151457A1 (en) Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
EP2294081A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE INTERACTION AND FUNCTION OF THE DOPAMINERGIC D1-D2 RECEPTOR
ZA200907546B (en) New progesterone receptor modulators
EP2004860A4 (en) METHYLATION OF ESTROGEN RECEPTOR ALPHA AND USE
HK1131787A1 (en) Oxa-steroids derivatives as selective progesterone receptor modulators
TH110389B (th) กลูโคคอร์ติคอยด์รีเซพเตอร์อะโกนิสท์ใหม่